Galderma sues Lupin over Oracea generic

07-12-2021

Alex Baldwin

Galderma sues Lupin over Oracea generic

JHVEphoto / Shutterstock.com

Galderma Laboratories has sued Lupin Pharmaceuticals alleging that it plans to manufacture and sell a generic version of Oracea (doxycycline) prior to the expiration of key patents.


Galderma Laboratories, Oracea, Lupin Pharmaceuticals, Oracea, Patents, generics, Federal Circuit, DRI Healthcare Trust

LSIPR